Actualités

Yahoo Finance Markets and Data Editor Jared Blikre tracks the riskiest parts of the market in today's Chart of the Day.

Tech stocks were mixed late Thursday afternoon, with the State Street Technology Select Sector SPDR

Yeti stock is tumbling today despite meeting analysts' expectations for the second quarter.

Strong earnings may no longer be enough for chip investors

RVII opened at $22.50 after pricing 8 million shares at $25

Cisco just blew past analyst expectations by a wide margin, yet shares are sliding. CEO Chuck Robbins says the skeptics are missing something fundamental about who is actually writing the checks for AI infrastructure.

Ackman Bets on Netflix Again After Painful 2022 Exit

Hertz was one of the worst-performing stocks in Pershing Square’s investment portfolio this year through August 11, subtracting 1.1% from gross performance, the firm said.

The growth case for Archer Aviation is getting stronger.

Micron Stock Surges Again as AI Boom Reignites Memory Trade

In July it ranked 13th among 16 retailers

OpenAI said Thursday that Chief Revenue Officer Denise Dresser is leaving, marking the latest depart

Pershing Square believes Azure capacity investment and Microsoft 365's embedded position can sustain high-teens earnings growth.

Australia's escalating enforcement could test whether Meta's automated age-detection systems satisfy regulators considering substantially higher penalties.

Both stocks have been on similar trajectories since SpaceX went public.

IBM plans to train and certify tens of thousands of consultants on OpenAI's technologies as part of this deal.

Bloomberg's James Crombie joins Emily Graffeo on "Real Yield."  Bond traders dialed back measures of credit risk associated with Nvidia after the company said it would limit its exposure in a $500 billion plan to finance the type of AI investments that are driving demand for its computer chips.

Tougher enforcement raises the stakes for social media platforms.

S&P 500 Pushes to Record as Inflation Data Eases Fed Fears

AMD's balance sheet makes timing of move especially intriguing

Cisco Systems (CSCO) initial fiscal 2027 revenue outlook appears conservative, with UBS's analysis o

New targets could dramatically reshape Sandisk's investment case

Jim Cramer was supposed to be on vacation. Instead, the MadMoney host was looking at three critical market signals that, in his view, can tell investors all they need to know. Two of them were the usual suspects: bonds and oil. The third, though, was Nvidia (NVDA), a surprise, to say ...

Cerebras shares hammered after $450 million loss and weak hardware sales

The pharmaceutical giant just increased its dividend by 3.1%, now paying $5.36 a share annually.

A Korea-sparked overnight surge lit the fuse, but SanDisk's investor day dropped on top of an already-moving sector with some of these names still sitting deep in the red from last month. Here is what is actually driving the storage stack today and whether the momentum holds.

Mastercard's faster-growing services business could capture additional economics as AI agents initiate and authenticate more commercial transactions.

Index funds were supposed to bury active management, yet one fund with $360 billion in assets keeps writing checks to private AI companies that indexers cannot touch. What Capital Group built inside AGTHX defies the obituary Wall Street already wrote.

JPMorgan Chase stock has delivered a strong 166.0% total return over the past 5 years, and the latest intrinsic value work using the Excess Returns model now points to the shares trading at a discount, while traditional valuation checks paint a more mixed picture. That split leaves investors weighing a stock with solid long term performance against signals that are not fully one sided on value. Over 5 years, a 166.0% total return suggests JPMorgan Chase has already created substantial value...

Merck stock has almost doubled investors' money over the past five years, yet there is a clear split between valuation tools. A Discounted Cash Flow (DCF) estimate points to a sizeable gap to intrinsic value, while market based multiples suggest the shares are already pricing in a lot of optimism. Merck has returned 99.7% over five years, which puts recent gains in focus as investors weigh how much future growth is already reflected in the price. Ongoing investment in oncology and new...